Boniva vs. Reclast
See how Boniva and Reclast compare on approved uses, dosing, side effects, and cost.
Key Takeaways
Boniva is a once-monthly oral tablet for postmenopausal osteoporosis, while Reclast is a once-yearly or once-every-two-years IV infusion approved for a wider range of bone conditions, including in men and steroid users.
Both drugs are nitrogen-containing bisphosphonates that slow bone breakdown, but Boniva's most common side effects involve digestion and muscles, while Reclast's center on a short-term flu-like reaction after the infusion.
The choice often comes down to how a patient prefers to take medication: a monthly pill at home with strict timing rules, or a yearly clinic visit with a chance of short-term flu-like symptoms.
Boniva vs. Reclast Drug Summary
Boniva
Boniva (ibandronate) is a nitrogen-containing bisphosphonate used to treat and prevent osteoporosis in postmenopausal women. It slows the natural breakdown of bone, which helps preserve bone density and lowers fracture risk. Boniva is taken as a tablet by mouth once a month, first thing in the morning on an empty stomach.
Reclast
Reclast (zoledronic acid) is a nitrogen-containing bisphosphonate used to treat and prevent osteoporosis in postmenopausal women, and it also treats men with osteoporosis, steroid-induced bone loss, and Paget's disease of bone. It works the same way as Boniva, slowing bone breakdown to protect bone density. Reclast is given as a single IV infusion, once a year for treatment or once every two years for prevention.
Boniva vs. Reclast Side Effects
Boniva
Reclast
Boniva vs. Reclast Dosage
Boniva
Reclast
| STAGE | DOSE | WHEN |
| Starting dose | 150 mg once monthly | At the start |
| Maximum dose | 150 mg once monthly | Same as starting |
| Dose changes | None | Fixed dose |
| STAGE | DOSE | WHEN |
| Starting dose | 5 mg IV infusion | At the start |
| Maximum dose | 5 mg IV infusion | Same as starting |
| Dose changes | None | Fixed dose |
Boniva
| STAGE | DOSE | WHEN |
| Starting dose | 150 mg once monthly | At the start |
| Maximum dose | 150 mg once monthly | Same as starting |
| Dose changes | None | Fixed dose |
Reclast
| STAGE | DOSE | WHEN |
| Starting dose | 5 mg IV infusion | At the start |
| Maximum dose | 5 mg IV infusion | Same as starting |
| Dose changes | None | Fixed dose |
Boniva vs. Reclast Indications
Boniva
Boniva is FDA-approved to treat and prevent osteoporosis in postmenopausal women. It works by slowing the natural breakdown of bone, which helps preserve bone density and lowers the risk of spine fractures. It is not approved for osteoporosis in men or for use in children.
Treatment of osteoporosis in postmenopausal women
Prevention of osteoporosis in postmenopausal women
Not approved for osteoporosis in men
Not approved for pediatric use
Reclast
Reclast is FDA-approved for a broader range of bone conditions than Boniva. It treats and prevents osteoporosis in postmenopausal women, increases bone mass in men with osteoporosis, treats and prevents glucocorticoid-induced osteoporosis, and treats Paget's disease of bone.
Treatment of osteoporosis in postmenopausal women
Prevention of osteoporosis in postmenopausal women
Increasing bone mass in men with osteoporosis
Treatment and prevention of glucocorticoid-induced osteoporosis
Boniva vs. Reclast Pros and Cons
Boniva
Boniva offers the convenience of a pill taken at home instead of a clinic visit, but its monthly schedule and strict dosing rules require more day-to-day effort than Reclast's yearly infusion. Coverage varies by plan, and prior authorization is common for either drug.
Pros
Taken as a pill at home, no clinic visit needed
No infusion-related flu-like reactions
Lower reported risk of acute kidney injury than IV bisphosphonates
Renal caution starts at a lower threshold than Reclast's contraindication
Cons
Must stay upright for 60 minutes after each dose
Requires an empty stomach and delayed breakfast each month
Not approved for men or pediatric osteoporosis
More frequent dosing (monthly) than Reclast's yearly infusion
Reclast
Reclast trades a daily or monthly pill routine for a single yearly (or less frequent) infusion, but that convenience comes with a clinic visit and a higher chance of short-term flu-like symptoms after each dose. Coverage typically falls under the medical benefit rather than a pharmacy plan.
Pros
Only one infusion per year, or every two years for prevention
Approved for men, steroid-induced osteoporosis, and Paget's disease
No fasting or upright-posture rules since it's given by IV
Given by a healthcare professional, removing at-home adherence guesswork
Cons
Requires an in-office IV infusion visit for each dose
Acute flu-like symptoms are common, especially after the first infusion
Contraindicated, not just cautioned, below 35 mL/min kidney function
Rare reports of acute kidney injury following infusion
Common Symptoms and Related Diseases You Can Explore
Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.